FDA inspection
GBA Pharma GmbH: FDA inspection ending Dec 11, 2024
FDA inspection 1261571 · No Action Indicated (NAI) · Neuried
Key facts
| Inspection ID | 1261571 |
|---|---|
| Firm | GBA Pharma GmbH |
| FEI number | 3004477049 |
| Address | Anna-Sigmund-Strasse 7 |
| City | Neuried |
| Country | Germany |
| Fiscal year | 2025 |
| Inspection end date | Dec 11, 2024 |
| Classification | No Action Indicated (NAI) |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
At a glance
- None Citations
- None Posted citations
- No Warning letter followed
- No Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data